Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

INZY holding history

Inozyme Pharma, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INZY overviewAll 13F holders of INZYFull Q4 2025 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of INZY by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−2,498,649−100.0%Sold outHolders
Q2 20252,498,649$9.99M<0.1%−259,829−9.4%ReducedHolders
Q1 20252,758,478$2.51M<0.1%+125,229+4.8%AddedHolders
Q4 20242,633,249$7.29M<0.1%+8,911+0.3%AddedHolders
Q3 20242,624,338$13.7M<0.1%−4,971−0.2%ReducedHolders
Q2 20242,629,309$11.7M<0.1%+210,289+8.7%AddedHolders
Q1 20242,419,020$18.5M<0.1%+33,998+1.4%AddedHolders
Q4 20232,385,022$10.2M<0.1%+108,937+4.8%AddedHolders
Q3 20232,276,085$9.56M<0.1%+880,175+63.1%AddedHolders
Q2 20231,395,910$7.78M<0.1%+67,620+5.1%AddedHolders
Q1 20231,328,290$7.61M<0.1%−15,332−1.1%ReducedHolders
Q4 20221,343,622$1.41M<0.1%+5590.0%AddedHolders
Q3 20221,343,063$3.60M<0.1%−11,153−0.8%ReducedHolders
Q2 20221,354,216$6.46M<0.1%+864,603+176.6%AddedHolders
Q1 2022489,613$2.00M<0.1%+894+0.2%AddedHolders
Q4 2021488,719$3.33M<0.1%−122,466−20.0%ReducedHolders
Q3 2021611,185$7.08M<0.1%+275,899+82.3%AddedHolders
Q2 2021335,286$5.71M<0.1%−5,678−1.7%ReducedHolders
Q1 2021340,964$6.75M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.